4536.T
4536.T
JP3336000009
SANTEN PHARMACEUTICAL CO
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
541.04B EUR
685.91B EUR
594.78B EUR
Enterprise Value
461.63B EUR
685.91B EUR
513.91B EUR
Valuation Multiples
Trailing P/E
14.8x
--
--
Forward P/E
15.59x
--
--
Price to Sales
1.85x
--
--
Price to Book
1.8x
--
2x
EV/Revenue
1.58x
--
--
EV/EBITDA
7.06x
--
--
Price to FCF (P/FCF)
25.04x
--
--
EV/FCF
21.37x
--
--
FCF Yield
3.99%
--
--
ende